Skip to main content
Premium Trial:

Request an Annual Quote

ABL Acquires Assets of Evivar Medical

NEW YORK (GenomeWeb News) – Advanced Biological Laboratories, a Luxembourg-based developer of informatics tools for personalized medicine, today announced that it has acquired all of the assets of Evivar Medical for an undisclosed amount.

The acquisition includes Melbourne, Australia-based Evivar's hepatitis B and C virus web-based decision support tools for clinicians and associated viral genome analysis systems SeqHepB and SeqHepC, its intellectual property portfolio, and all related commercial arrangements and operations. The SeqHepB and SeqHepC systems are used for hepatitis B and C therapy management and can be used to identify mutations present in the infected persons, including predicting resistance levels to commercially available drugs, the firms said.

"Our acquisition of Evivar Medical assets will add value and allows ABL to further expand its Virology portfolio from HIV to include Hepatitis disease management," ABL President and CEO Chalom Sayada.

The Evivar tools will complement ABL's existing data tools including its TherapyEdge, ViroScore, and DeepChek products.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.